Literature DB >> 2715081

Modification of radiosensitivity and recovery from X ray damage in vitro by retinoic acid.

H P Rutz1, J B Little.   

Abstract

We studied the effects of all-trans retinoic acid (RA) combined with X-irradiation on confluent cultures of human breast cancer (MCF-7) and melanoma (C-143) cell lines, as well as in a normal human diploid fibroblast strain (AG 1522). RA in non-cytotoxic concentrations was a potent inhibitor of confluent holding recovery of potentially lethal damage (PLD repair) for all three cell types. A complete inhibition of recovery was observed at lower RA concentrations in the tumor lines than in the fibroblast strain. Exposure to RA prior to and during irradiation resulted in a radiosensitizing effect that was similar in MCF-7 and AG 1522 cells. The implications of these findings are discussed in terms of the potential value of retinoids as biological response modifiers for the clinical radiotherapy of cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715081     DOI: 10.1016/0360-3016(89)90300-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Unexpected radiation protection with 13-cis-retinoic acid plus interferon alpha-2a.

Authors:  K A Mason; P J Tofilon
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.

Authors:  N Voravud; S M Lippman; R S Weber; G I Rodriquez; D Yee; I W Dimery; C L Earley; D D Von Hoff; W K Hong
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

3.  Retinoic acid and cancer treatment.

Authors:  Mei-Chih Chen; Shih-Lan Hsu; Ho Lin; Tsung-Ying Yang
Journal:  Biomedicine (Taipei)       Date:  2014-11-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.